Effects of the anti-interleukin-6 receptor antibody, tocilizumab, on serum lipid levels in patients with rheumatoid arthritis (Q60809264)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20024554%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

Effects of the anti-interleukin-6 receptor antibody, tocilizumab, on serum lipid levels in patients with rheumatoid arthritis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20024554%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

0 references

1 reference

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20024554%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

Shin-ya Kawashiri

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20024554%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Atsushi Kawakami

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20024554%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Satoshi Yamasaki

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20024554%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Takahiro Imazato

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20024554%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Naoki Iwamoto

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20024554%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Keita Fujikawa

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20024554%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Toshiyuki Aramaki

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20024554%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Hideki Nakamura

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20024554%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Hiroaki Ida

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20024554%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Tomoki Origuchi

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20024554%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Yukitaka Ueki

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20024554%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Katsumi Eguchi

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20024554%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

publication date

19 December 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20024554%20AND%20SRC:MED&resulttype=core&format=json

Rheumatology International

15 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20024554%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20024554%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

451-456

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20024554%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20024554%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00296-009-1303-y

15 January 2020

exact match

0 references

cites work

The influence of recombinant human interleukin-6 on blood and immune parameters in middle-aged and old rhesus monkeys

1 reference

12 December 2020

Sustained changes in lipid profile and macrophage migration inhibitory factor levels after anti-tumour necrosis factor therapy in rheumatoid arthritis

1 reference

12 December 2020

Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis

1 reference

12 December 2020

Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis

1 reference

12 December 2020

Toxicity, pharmacokinetics, and dose-finding study of repetitive treatment with the humanized anti-interleukin 6 receptor antibody MRA in rheumatoid arthritis. Phase I/II clinical study

1 reference

12 December 2020

Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab

1 reference

12 December 2020

Treatment with TNF blockers and mortality risk in patients with rheumatoid arthritis

1 reference

12 December 2020

Cytokines decrease apolipoprotein accumulation in medium from Hep G2 cells.

1 reference

12 December 2020

Changes in lipid profile during infliximab and corticosteroid treatment in rheumatoid arthritis

1 reference

12 December 2020

Lipid profiles among US elderly with untreated rheumatoid arthritis--the Third National Health and Nutrition Examination Survey.

1 reference

12 December 2020

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

12 December 2020

The pathophysiologic roles of interleukin-6 in human disease

1 reference

12 December 2020

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1 reference

12 December 2020

Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial

1 reference

12 December 2020

Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies

1 reference

12 December 2020

Dual control of C-reactive protein gene expression by interleukin-1 and interleukin-6.

1 reference

12 December 2020

Modest but sustained increase of serum high density lipoprotein cholesterol levels in patients with inflammatory arthritides treated with infliximab

1 reference

12 December 2020

The mortality of rheumatoid arthritis

1 reference

12 December 2020

Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis

1 reference

12 December 2020

Accelerated atherosclerosis in rheumatoid arthritis

1 reference

12 December 2020

Recombinant human interleukin 6 is a potent inducer of the acute phase response and elevates the blood platelets in nonhuman primates

1 reference

12 December 2020

Effects of anti-TNF-alpha treatment on lipid profile in patients with active rheumatoid arthritis

1 reference

12 December 2020

Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register

1 reference

12 December 2020

10.1007/S00296-009-1303-Y

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20024554%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference